Literature DB >> 8034569

Cloning and functional expression of endothelin-converting enzyme from rat endothelial cells.

K Shimada1, M Takahashi, K Tanzawa.   

Abstract

Endothelin (ET) is a 21-residue potent vasoconstrictive peptide produced by vascular endothelial cells and formed from its precursor, big endothelin (big ET), by endothelin-converting enzyme (ECE). Here we report the cloning and functional expression of a complementary DNA encoding a rat ECE from endothelial cells. Rat ECE is a highly glycosylated protein consisting of 10 possible N-linked glycosylation sites, a zinc-binding domain, and a single membrane-spanning region. It has structural and sequence homology to neutral endopeptidase and Kell blood group protein, a putative neutral endopeptidase. Monoclonal antibody risen against purified rat lung ECE recognized broad glycosylated bands in membrane fractions prepared from both rat lung and COS cells transfected with a rat ECE expression vector. Expressed ECE was inhibited by phosphoramidon, but not by thiorphan. It also cleaved big ET-1 efficiently but not big ET-2 or big ET-3. Northern blot analysis revealed that ECE messenger RNA is widely expressed in many tissues.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8034569

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Molecular cloning of MADM: a catalytically active mammalian disintegrin-metalloprotease expressed in various cell types.

Authors:  L Howard; X Lu; S Mitchell; S Griffiths; P Glynn
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

Review 2.  Endothelin A receptor antagonists in congestive heart failure: blocking the beast while leaving the beauty untouched?

Authors:  L E Spieker; G Noll; F T Ruschitzka; T F Lüscher
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

3.  Histochemical distribution of endothelin-converting enzyme subtypes in Podarcis sicula (Squamata, Lacertidae) tissues.

Authors:  Salvatore Valiante; Marina Prisco; Maria De Falco; Francesca Virgilio; Rosaria Sciarrillo; Piero Andreuccetti; Vincenza Laforgia; Lorenzo Varano
Journal:  J Anat       Date:  2005-10       Impact factor: 2.610

4.  Mutagenesis of Glu403 to Cys in rabbit neutral endopeptidase-24.11 (neprilysin) creates a disulphide-linked homodimer: analogy with endothelin-converting enzyme.

Authors:  M V Hoang; C E Sansom; A J Turner
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

5.  Recombinant human endothelin-converting enzyme ECE-1b is located in an intracellular compartment when expressed in polarized Madin-Darby canine kidney cells.

Authors:  A Azarani; G Boileau; P Crine
Journal:  Biochem J       Date:  1998-07-15       Impact factor: 3.857

6.  Rat endothelin-converting enzyme-1 forms a dimer through Cys412 with a similar catalytic mechanism and a distinct substrate binding mechanism compared with neutral endopeptidase-24.11.

Authors:  K Shimada; M Takahashi; A J Turner; K Tanzawa
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

7.  Role of the neutral endopeptidase 24.11 in the conversion of big endothelins in guinea-pig lung parenchyma.

Authors:  N Lebel; P D'Orléans-Juste; A Fournier; P Sirois
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

8.  Endothelin-converting enzyme-1 degrades internalized somatostatin-14.

Authors:  Dirk Roosterman; Cordula Kempkes; Graeme S Cottrell; Benjamin E Padilla; Nigel W Bunnett; Christoph W Turck; Martin Steinhoff
Journal:  Endocrinology       Date:  2008-02-14       Impact factor: 4.736

9.  Protein Kinase C Regulates the Cell Surface Activity of Endothelin-Converting Enzyme-1.

Authors:  A Ian Smith; Rebecca A Lew; Walter G Thomas; Nathalie Tochon-Danguy
Journal:  Int J Pept Res Ther       Date:  2006-05-19       Impact factor: 1.931

10.  Ambrisentan for the treatment of pulmonary arterial hypertension.

Authors:  Brian Casserly; James R Klinger
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.